Artificial Blood Market Expands with Trauma Care Needs and Shortage of Donor Blood | Hemarina, KaloCyte, Inc., SpheriTech Limited, and Hemoglobin Oxygen Therapeutics LLC among others.

Global Artificial Blood Market reached US$ 3760.00 million in 2023 and is expected to reach US$ 7194.83 million by 2031, growing at a CAGR of 8.7% during the forecast period 2024-2031.

Artificial Blood Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With increasing trauma cases, surgical demand, and challenges in blood supply logistics, the report delivers strategic insights for stakeholders in the development and commercialization of synthetic blood substitutes from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/artificial-blood-market?ophp

Artificial blood refers to blood substitutes designed to mimic and fulfill some functions of biological blood, primarily oxygen transport. Still largely in R&D or early clinical stages, the market is being driven by the need for alternatives during shortages, trauma care, and in cases where blood transfusions are risky. Technological innovations and military and emergency applications are fueling market interest and investment.

Artificial Blood Market Competitors Overview:

Hemarina, KaloCyte, Inc., SpheriTech Limited, and Hemoglobin Oxygen Therapeutics LLC among others.

Important Industry Updates of 2025:

✅ In March 2025 - Nara Medical University (Japan) began the world's first human trials of hemoglobin vesicles (HbVs)-lipid-encased hemoglobin derived from expired donor blood. Results in healthy volunteers up to 400 mL showed no serious adverse events. Safety and oxygen-carrying function are under evaluation

Methodology and Scope

The Artificial Blood Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/artificial-blood-market?ophp

Artificial Blood Market Segments Overview:

∎ By Product Type
Hemoglobin-based Oxygen Carriers
Perfluorocarbon Emulsion

∎ By Source
Human Hemoglobin
Animal Hemoglobin
Stem Cells
Synthetic Polymers
Microorganisms
Others

∎ By Process
Synthetic Production
Chemical Isolation
Recombinant Biochemical Technology

∎ By Application
Anemia
Organ Transplantation
Injuries & Trauma
Cardiovascular Diseases
Maternal Conditions
Others

∎ By End-User
Hospitals
Clinics
Blood Banks
Research Institutes
Others

The hemoglobin-based oxygen carriers (HBOCs) segment dominates as they are actively developed for trauma and emergency use, providing oxygen delivery without needing blood type matching.

Regional Overview for Artificial Blood Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America holds the largest market share for artificial blood, supported by robust R&D, ongoing clinical trials, and defense-related applications. Europe is the fastest growing region, with increasing investments in trauma care and synthetic blood sub

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/customize/artificial-blood-market?ophp?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Artificial Blood market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Artificial Blood market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.